S. Miller

A. Kirk, S. Miller, B. Hering, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes

Nagendra P. Palani, S. Miller, B. Hering, 2019, Nature Communications.

Transient B-Cell Depletion Combined With Apoptotic Donor Splenocytes Induces Xeno-Specific T- and B-Cell Tolerance to Islet Xenografts

J. Ulaszek, S. Miller, B. Hering, 2013, Diabetes.

Glial toll-like receptor signaling in central nervous system infection and autoimmunity

S. Miller, P. Carpentier, D. S. Duncan, 2008, Brain, Behavior, and Immunity.

Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.

S. Miller, D. Turley, 2010, Results and problems in cell differentiation.

Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor.

S. Miller, A. M. Ercolini, M. Degutes, 2008, Journal of autoimmunity.

Demyelinating Disease Models of Central Nervous System Mechanisms of Immunopathology in Murine

S. Miller, A. M. Ercolini, Anne M. Ercolini, 2006 .

Initiation and Exacerbation of Autoimmune Demyelination of the Central Nervous System via Virus-Induced Molecular Mimicry: Implications for the Pathogenesis of Multiple Sclerosis

S. Miller, H. Anger, J. Olson, 2005, Journal of Virology.

Viral Delivery of an Epitope from Haemophilus influenzae Induces Central Nervous System Autoimmune Disease by Molecular Mimicry1

S. Miller, H. Anger, J. Croxford, 2005, The Journal of Immunology.

Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis.

S. Miller, J. Olson, J. Croxford, 2002, Autoimmunity reviews.

Functional Activation of Myelin-Specific T Cells by Virus-Induced Molecular Mimicry1

S. Miller, T. Eagar, J. Olson, 2002, The Journal of Immunology.

Cells by Virus-Induced Molecular Mimicry Functional Activation of Myelin-Specific T

S. Miller, T. Eagar, J. Olson, 2002 .

Degenerate antigen recognition by CD4+ effector T cells in experimental autoimmune encephalomyelitis

S. Miller, N. Karandikar, B. Mcrae, 1997, Journal of Neuroimmunology.

Differential activation of astrocytes by innate and adaptive immune stimuli

S. Miller, W. Karpus, J. Olson, 2005, Glia.

Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.

S. Miller, Dan-ling Xu, S. Prasad, 2012, The review of diabetic studies : RDS.

ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms

Aaron J. Martin, S. Miller, D. Kaufman, 2008, Proceedings of the National Academy of Sciences.

A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice.

S. Miller, M. T. Getts, Maureen H Richards, 2010, Virology.

PD‐1 ligands expressed on myeloid‐derived APC in the CNS regulate T‐cell responses in EAE

Lieping Chen, S. Miller, T. Shin, 2008, European journal of immunology.

NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses

Denis Gris, Z. Ye, H. Iocca, 2010, The Journal of Immunology.

Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases

S. Miller, W. Karpus, C. Vanderlugt, 1995, Immunological reviews.

-Activated SJL/J Astrocytes γ Cells by IFN- T B7-1-Dependent Activation of Encephalitogenic Presentation of Proteolipid Protein Epitopes and

L. Matis, S. Miller, K. Gordon, 2013 .

J Astrocytes γ Cells by IFN-TB 7-1-Dependent Activation of Encephalitogenic Presentation of Proteolipid Protein Epitopes and and

L. Matis, S. Miller, K. Gordon, 1998 .

Two models of multiple sclerosis: Experimental allergic encephalomyelitis (EAE) and theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison

S. Miller, M. D. Dal Canto, Byung S. Kim, 1995, Microscopy research and technique.

A Critical Role for B7/CD28 Costimulation in Experimental Autoimmune Encephalomyelitis: A Comparative Study Using Costimulatory Molecule-Deficient Mice and Monoclonal Antibody Blockade1

J. Bluestone, S. Miller, B. Salomon, 2000, The Journal of Immunology.

De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis1

S. Miller, J. Ting, S. Tompkins, 2002, The Journal of Immunology.

Cutting Edge: Central Nervous System Plasmacytoid Dendritic Cells Regulate the Severity of Relapsing Experimental Autoimmune Encephalomyelitis1

S. Miller, G. Goings, Samantha L. Bailey-Bucktrout, 2008, The Journal of Immunology.

Antigen-Fixed Leukocytes Tolerize Th2 Responses in Mouse Models of Allergy

S. Miller, P. Bryce, Chia-Lin Hsu, 2011, The Journal of Immunology.

Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells1

S. Ziegler, S. Miller, D. Kasprowicz, 2006, The Journal of Immunology.

Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis.

J. Strominger, S. Miller, T. Eagar, 2005, Proceedings of the National Academy of Sciences of the United States of America.

DIABETIC STUDIES The Review of Chapter III . 3 Tolerance Strategies Employing Antigen-Coupled Apoptotic Cells and Carboxylated PLG Nanoparticles for the Treatment of Type 1 Diabetes

S. Miller, Dan-ling Xu, S. Prasad, 2013 .

Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS

S. Miller, K. L. Neville, J. Padilla, 2002, Journal of Neuroimmunology.

CD43 Regulates Th2 Differentiation and Inflammation

S. Miller, Amélie Collins, B. Clay, 2008 .

InflammationCD43 Regulates Th2 Differentiation and

S. Miller, Amélie Collins, B. Clay, 2022 .

Autoimmune Encephalomyelitis Severity of Relapsing Experimental Plasmacytoid Dendritic Cells Regulate the Cutting Edge: Central Nervous System

S. Miller, G. Goings, Samantha L. Bailey-Bucktrout, 2008 .

Herpesvirus Entry Mediator Binding Partners Mediate Immunopathogenesis of Ocular Herpes Simplex Virus 1 Infection

R. Longnecker, S. Miller, S. Park, 2020, mBio.

Peripheral Tolerance Induction Using Ethylenecarbodiimide-Fixed APCs Uses both Direct and Indirect Mechanisms of Antigen Presentation for Prevention of Experimental Autoimmune Encephalomyelitis1

S. Miller, D. Turley, 2007, The Journal of Immunology.

Encephalomyelitis Presentation for Prevention of Experimental Direct and Indirect Mechanisms of Antigen Ethylenecarbodiimide-Fixed APCs Uses both Peripheral Tolerance Induction Using

S. Miller, D. Turley, 2007 .

Theiler ' s virus infection site , cellular in fi ltration and T cell stimulation in the CNS

S. Miller, G. Goings, B. Kang, 2010 .

This information is current as Distinct Models of Multiple Sclerosis Nervous System Pathology in Two Clinically Cytokines Parallels Progression of Central Differential Expression of Inflammatory

S. Miller, C. Vanderlugt, W. Begolka, 1998 .

Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.

S. Ostrovidov, S. Miller, M. D. Dal Canto, 2002, The Journal of clinical investigation.

CNS dendritic cells: Critical participants in CNS inflammation?

S. Miller, E. McMahon, S. Bailey, 2006, Neurochemistry International.

Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

S. Miller, P. Bryce, Charles B. Smarr, 2013, Critical reviews in immunology.

Theiler’s Murine Encephalomyelitis Virus-Induced Demyelinating Disease (TMEV-IDD) and Autoimmunity

S. Miller, Emily M. L. Chastain, 2015 .

Immunopathological mechanisms in multiple sclerosis

S. Miller, J. Podojil, 2006 .

Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis

S. Bhattacharyya, J. Varga, S. Miller, 2020, iScience.

Heat shock proteins and experimental autoimmune encephalomyelitis II: environmental infection and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis

Radhey S. Gupta, S. Miller, L. Kotilinek, 1998, Journal of Neuroimmunology.

Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy

S. Miller, Yanni Yu, J. Meeks, 2022, Frontiers in Immunology.

Epitope spreading

S. Miller, C. J. Vanderlugt, 1996, Current Opinion in Immunology.

Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

S. Miller, D. McCarthy, Maureen H Richards, 2012, Methods in molecular biology.

Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

S. Miller, J. Olson, J. Croxford, 2004, Methods in molecular medicine.

Nanoparticles Containing an Insulin–ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells

S. Miller, A. Goodspeed, K. Haskins, 2019, The Journal of Immunology.

The role of CTLA‐4 in induction and maintenance of peripheral T cell tolerance

Nitin J. Karandikar, J. Bluestone, S. Miller, 2002, European journal of immunology.

Current landscape for T-cell targeting in autoimmunity and transplantation.

Aaron J. Martin, S. Miller, K. Wood, 2011, Immunotherapy.

16 – Helper T-cell subsets and control of the inflammatory response

S. Miller, T. Eagar, 2012 .

Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.

S. Miller, B. Theien, C. Vanderlugt, 2003, Blood.

γδ T Cell Subsets Play Opposing Roles in Regulating Experimental Autoimmune Encephalomyelitis1

S. Miller, G. Goings, Bernard, 2014 .

through Multiple TLRs Innate and Adaptive Immune Responses Microglia Initiate Central Nervous System

S. Miller, J. Olson, 2013 .

Direct Activation of Innate and Antigen-Presenting Functions of Microglia following Infection with Theiler's Virus

S. Miller, J. Olson, A. M. Girvin, 2001, Journal of Virology.

Rapamycin‐Conditioned Donor Dendritic Cells Differentiate CD4+CD25+Foxp3+ T Cells In Vitro with TGF‐β1 for Islet Transplantation

S. Miller, M. Degutes, T. Kheradmand, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Ethylenecarbodiimide-Fixed Donor Splenocyte Infusions Differentially Target Direct and Indirect Pathways of Allorecognition for Induction of Transplant Tolerance

S. Miller, Xunrong Luo, Z. Zhang, 2012, The Journal of Immunology.

Allorecognition for Induction of Transplant Direct and Indirect Pathways of Splenocyte Infusions Differentially Target Ethylenecarbodiimide-Fixed Donor

S. Miller, Z. Zhang, J. Bryant, 2012 .

The role of T cells and the innate immune system in the pathogenesis of theiler's virus demyeliating disease

S. Miller, J. Olson, 2005 .

Interferon-γ-Oligodendrocyte Interactions in the Regulation of Experimental Autoimmune Encephalomyelitis

S. Miller, B. Popko, R. Balabanov, 2007, The Journal of Neuroscience.

Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles.

Ryan M. Pearson, S. Miller, L. Shea, 2019, Nanomedicine : nanotechnology, biology, and medicine.

Split tolerance of Thl and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus

J. Peterson, S. Miller, W. Karpus, 1993, European journal of immunology.

Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.

S. Miller, L. Shea, D. Getts, 2017, Journal of autoimmunity.

CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.

S. Miller, W. Karpus, I. Charo, 2007, Viral immunology.

The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter

S. Miller, Hosung Jung, Richard J. Miller, 2011, Neurobiology of Disease.

Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma

A. Shilatifard, A. G. Robertson, S. Miller, 2022, Science advances.

Prevention of Autoimmune Myocarditis Through the Induction of Antigen-Specific Peripheral Immune Tolerance

S. Miller, D. Engman, L. Godsel, 2001, Circulation.

γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.

B. Malissen, S. Miller, G. Goings, 2014, Cellular immunology.

γδ T Cell Subsets Play Opposing Roles in Regulating Experimental Autoimmune Encephalomyelitis 1

B. Malissen, S. Miller, G. Goings, 2014 .

The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Stephen D Miller, S. Miller, C. Harp, 2014, Handbook of clinical neurology.

TGF-β–Induced Myelin Peptide-Specific Regulatory T Cells Mediate Antigen-Specific Suppression of Induction of Experimental Autoimmune Encephalomyelitis

S. Miller, Hong Zhang, Xunrong Luo, 2010, The Journal of Immunology.

Act1, scene brain: astrocytes play a lead role.

Liang Zhou, S. Miller, J. M. Rodgers, 2010, Immunity.

Effects of cannabinoid treatment on Chagas disease pathogenesis: balancing inhibition of parasite invasion and immunosuppression

S. Miller, D. Engman, K. Tyler, 2005, Cellular microbiology.

Targeting Th17 Cells for Therapy of Multiple Sclerosis

Aaron J. Martin, S. Miller, 2013 .

Targeting Th17 cells in CNS immune pathology

Aaron J. Martin, S. Miller, 2009 .

Arresting autoimmunity by blocking β-arrestin 1

S. Miller, T. J. Frederick, 2007, Nature Immunology.

Efficient technique for immortalization of murine microglial cells relevant for studies in murine models of multiple sclerosis

S. Zamvil, S. Miller, J. Olson, 2003, Journal of Neuroscience Methods.

Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses

S. Miller, M. C. Canto, L. Howard, 2002, Journal of Neuroimmunology.

Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates.

Ryan M. Pearson, S. Miller, L. Shea, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Alteration in the level of interferon-γ results in acceleration of Theiler's virus-induced demyelinating disease

S. Miller, P. Meide, L. Pullen, 1994, Journal of Neuroimmunology.

Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells.

S. Miller, K. Gordon, C. Welsh, 2002, Blood.

CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis

J. Bluestone, S. Miller, N. Karandikar, 2000, Journal of Neuroimmunology.

CD28 Costimulatory Blockade Exacerbates Disease Severity and Accelerates Epitope Spreading in a Virus-Induced Autoimmune Disease

J. Bluestone, S. Miller, M. D. Dal Canto, 2000, Journal of Virology.

Characterization of and Functional Antigen Presentation by Central Nervous System Mononuclear Cells from Mice Infected with Theiler’s Murine Encephalomyelitis Virus

S. Miller, C. Vanderlugt, H. Lipton, 1998, Journal of Virology.

Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease

J. Bluestone, S. Miller, N. Karandikar, 1998, Journal of Neuroimmunology.

EncephalomyelitisRelapsing Experimental Autoimmune and Function During the Course of Murine Tissue-Specific Up-Regulation of B7-1 Expression

J. Bluestone, S. Miller, N. Karandikar, 1998 .

Theiler's Murine Encephalomyelitis Virus (TMEV) Infection in Mice as a Model for Multiple Sclerosis

R. Fujinami, S. Miller, H. Lipton, 1986 .

Immunogenetics, Resistance, and Susceptibility to Theiler’s Virus Infection

S. Miller, R. Melvold, 2005 .

The role of protective CD8+ T cells in resistance of BALB/c mice to Theiler's murine encephalomyelitis virus-induced demyelinating disease: regulatory vs. lytic

S. Miller, C. Vanderlugt, S. M. Nicholson, 1999, Journal of Neuroimmunology.

Normal Th 1 development following long-term therapeutic blockade of CD 154-CD 40 in experimental autoimmune encephalomyelitis

S. Ostrovidov, S. Miller, Cassandra E. Smith, 2002 .

CNS Expression of B7-H1 Regulates Pro-Inflammatory Cytokine Production and Alters Severity of Theiler's Virus-Induced Demyelinating Disease

S. Miller, D. S. Duncan, 2011, PloS one.

Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE

Nitin J. Karandikar, J. Bluestone, D. Lenschow, 1997, Journal of Neuroimmunology.

Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis

S. Karlik, S. Miller, Robert H Miller, 2019, Scientific Reports.

Theiler's Virus‐Mediated Autoimmunity

S. Miller, S. Tompkins, K. Fuller, 2002, Annals of the New York Academy of Sciences.

Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

S. Miller, J. Podojil, D. Turley, 2007, Nature Reviews Immunology.

UpregulationTransplant Protection by Inhibiting CD154 Histocompatability Y Chromosome Antigen Carrying Male CD4 Epitopes Confer Ethylenecarbodiimide-Treated Splenocytes

Aaron J. Martin, S. Miller, G. Goings, 2010 .

Antigen-specific inhibition of the adoptive transfer of experimental autoimmune enceophalomyelitis in Lewis rats

S. Miller, P. Y. Paterson, L. Pope, 1992, Journal of Neuroimmunology.

Autoimmune Intervention by CD154 Blockade Prevents T Cell Retention and Effector Function in the Target Organ1

S. Miller, L. Howard, 2001, The Journal of Immunology.

Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization

Ryan M. Pearson, S. Miller, L. Shea, 2016, Proceedings of the National Academy of Sciences.

Effector Function in the Target Organ Blockade Prevents T Cell Retention and Autoimmune Intervention by CD154

S. Miller, L. Howard, 2001 .

Experimental Autoimmune Encephalomyelitis in the Mouse

S. Miller, W. Karpus, 1996, Current protocols in immunology.

Specific Immunoregulation of the Induction and Effector Stages of Relapsing EAE via Neuroantigen‐Specific Tolerance Induction

S. Miller, M. Kennedy, L. Tan, 1991, Annals of the New York Academy of Sciences.

TGF-b–Induced Myelin Peptide-Specific Regulatory T Cells Mediate Antigen-Specific Suppression of Induction of Experimental Autoimmune Encephalomyelitis

S. Miller, Hong Zhang, Xunrong Luo, 2010 .

Autoimmune Encephalomyelitis Suppression of Induction of Experimental Regulatory T Cells Mediate Antigen-Specific Induced Myelin Peptide-Specific − β TGF-and

S. Miller, Hong Zhang, Xunrong Luo, 2010 .

Regulatory Cells T + CD 25 + Inactivation , Not Depletion , of CD 4 Antibody Injection Results in the Functional Cutting Edge : Anti-CD 25 Monoclonal

S. Ziegler, S. Miller, D. Kasprowicz, 2006 .

EncephalomyelitisActivation and Experimental Autoimmune T Cell + Enhances Autoreactive CD4 Glucocorticoid-Induced TNF Receptor Cutting Edge: Ligation of the

S. Miller, A. Kohm, Julie S. Williams, 2004 .

Theiler's Virus-Induced Demyelinating Disease

S. Miller, W. Karpus, R. Melvold, 1994 .

H-2 Genes in TMEV-Induced Demyelination, A Model for Multiple Sclerosis

S. Miller, H. Lipton, R. Melvold, 1987 .

Monocytes Prime Autoreactive T cells After Myocardial Infarction.

S. Miller, Xunrong Luo, E. Thorp, 2019, American journal of physiology. Heart and circulatory physiology.

Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions

S. Miller, Richard J. Miller, J. Podojil, 2015, Journal of Neuroimmune Pharmacology.

Innate and adaptive immune responses of the central nervous system.

S. Miller, E. McMahon, W. Begolka, 2006, Critical reviews in immunology.

Cross-Linking of CD80 on CD4+ T Cells Activates a Calcium-Dependent Signaling Pathway1

S. Miller, J. Podojil, Joseph R. Podojil, 2009, The Journal of Immunology.

This information is current as Pathway Activates a Calcium-Dependent Signaling T Cells + Cross-Linking of CD 80 on CD 4

S. Miller, J. Podojil, Joseph R. Podojil, 2008 .

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

S. Bhattacharyya, J. Varga, S. Miller, 2022, Nature Communications.

Lymphocytes from mice chronically infected with Theiler’s murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity

S. Miller, C. Vanderlugt, M. Calenoff, 2000, Journal of Neuroimmunology.

Differential recognition of sequences within the encephalitogenic region of myelin basic protein capable of eliciting cell-mediated immune responses in experimental autoimmune encephalomyelitis

S. Miller, P. Y. Paterson, M. K. Malotky, 1993, Journal of Neuroimmunology.

CD8-deficient SJL mice display enhanced susceptibility to Theiler’s virus infection and increased demyelinating pathology

S. Miller, M. D. Dal Canto, L. Haynes, 2001, Journal of NeuroVirology.

Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice

S. Miller, M. Mohindru, B. Kang, 2001, Journal of Neuroimmunology.

a negative regulator of autoimmune disease.

J. Bluestone, S. Miller, T. Walunas, 2003 .

CTLA-4 Regulates Expansion and Differentiation of Th1 Cells Following Induction of Peripheral T Cell Tolerance1

Nitin J. Karandikar, J. Bluestone, S. Miller, 2004, The Journal of Immunology.

The Use of Biodegradable Nanoparticles for Tolerogenic Therapy of Allergic Inflammation.

S. Miller, Charles B. Smarr, 2018, Methods in molecular biology.

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

S. Bhattacharyya, J. Varga, S. Miller, 2022, Nature Communications.

Nanoparticle dose and antigen loading attenuate antigen‐specific T‐cell responses

Ryan M. Pearson, S. Miller, L. Shea, 2022, Biotechnology and bioengineering.

Modulating lung immune cells by pulmonary delivery of antigen-specific nanoparticles to treat autoimmune disease

S. Miller, B. Moore, L. Shea, 2020, Science Advances.

Modifications of nitric oxide and sexual behavior in prenatally stressed male rats

S. Miller, 1999 .

Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds.

S. Miller, L. Shea, W. Yap, 2014, BioTechniques.

Ethylenecarbodiimide-Treated Splenocytes Carrying Male CD4 Epitopes Confer Histocompatability Y Chromosome Antigen Transplant Protection by Inhibiting CD154 Upregulation

Aaron J. Martin, S. Miller, G. Goings, 2010, The Journal of Immunology.

Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy

R. Longnecker, S. Miller, M. Kronenberg, 2017, Investigative ophthalmology & visual science.

Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.

Ryan M. Pearson, P. Saavalainen, S. Meri, 2020, Gastroenterology.

BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease

J. Peterson, S. Miller, S. M. Nicholson, 1994, Journal of Neuroimmunology.

In vivo reprogramming of immune cells: Technologies for induction of antigen‐specific tolerance

Ryan M. Pearson, Lonnie D Shea, Stephen D Miller, 2017, Advanced drug delivery reviews.

Virus infection, antiviral immunity, and autoimmunity

S. Miller, D. Getts, Rachael L. Terry, 2013, Immunological reviews.

CD8+ T cells from Theiler’s virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4+ T cells

S. Miller, C. Vanderlugt, L. Haynes, 2000, Journal of Neuroimmunology.

Biliary Atresia Is Associated with CD4+ Th1 Cell–Mediated Portal Tract Inflammation

R. Tucker, S. Miller, R. Sokol, 2004, Pediatric Research.

Characterization of a novel and spontaneous mouse model of inflammatory arthritis

S. Miller, E. McMahon, C. King, 2011, Arthritis research & therapy.

Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis.

S. Miller, J. Podojil, M. Padval, 2011, Cellular immunology.

Potential targeting of B7‐H4 for the treatment of cancer

S. Miller, J. Podojil, Joseph R. Podojil, 2017, Immunological reviews.

Suppressive Mechanisms Involving Sensitization and Tolerance in Contact Allergy

S. Miller, M. Sy, S. Miller, 1980, Immunological reviews.

Exploiting Apoptosis for Therapeutic Tolerance Induction

S. Miller, D. McCarthy, D. Getts, 2013, The Journal of Immunology.

Tolerance Induction Exploiting Apoptosis for Therapeutic

S. Miller, D. McCarthy, D. Getts, 2013 .

IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression

R. Ransohoff, S. Miller, D. Hambardzumyan, 2017, Nature Communications.

Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles

Jin Ma, Huiling Wu, Thomas M. Ashhurst, 2014, Science Translational Medicine.

ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis

S. Kaech, S. Miller, Calvin Law, 2021, Cell reports.

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

S. Bhattacharyya, J. Varga, S. Miller, 2022, Nature Communications.

Antigen-Specific Tolerance by Autologous Myelin Peptide–Coupled Cells: A Phase 1 Trial in Multiple Sclerosis

A. Lutterotti, M. Sospedra, Roland Martin, 2013, Science Translational Medicine.

Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities.

S. Miller, Cassandra E. Smith, 2006, Journal of autoimmunity.

Current theories for multiple sclerosis pathogenesis and treatment

S. Miller, D. Getts, Rachael L. Terry, 2012 .

CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function

S. Miller, W. Karpus, Rukiye-Nazan E. Dogan, 2011, Journal of leukocyte biology.

Future of multiple sclerosis therapy: combining antigen-specific immunotherapy with strategies to promote myelin repair

S. Miller, T. J. Frederick, 2006 .

Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis

S. Miller, B. Popko, J. Podojil, 2019, Brain : a journal of neurology.

Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis

S. Miller, G. Goings, Andrew P Robinson, 2014, PloS one.

Cytokine Control of Inflammation and Repair in the Pathology of Multiple Sclerosis

S. Miller, J. M. Rodgers, 2012, The Yale journal of biology and medicine.

Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

S. Miller, M. T. Getts, J. Podojil, 2011, Journal of autoimmunity.

Differential Outcome of Tolerance Induction in Naive versus Activated Theiler's Virus Epitope-Specific CD8+ Cytotoxic T Cells

S. Miller, M. T. Getts, Byung S. Kim, 2007, Journal of Virology.

T-cell response dynamics in animal models of multiple sclerosis: implications for immunotherapies

S. Miller, B. Schreiner, S. Bailey, 2007, Expert review of clinical immunology.

Genetic control of pathogenic mechanisms in autoimmune demyelinating disease

S. Miller, J. Russell, G. Suvannavejh, 2000, Journal of Neuroimmunology.

Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein

S. Miller, M. Kennedy, B. Mcrae, 1992, Journal of Neuroimmunology.

Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler’s Virus-Induced Autoimmunity

S. Miller, D. Getts, Emily M. L. Chastain, 2015, mBio.

Antigen Presentation in the CNS by Myeloid Dendritic Cells Drives Progression of Relapsing Experimental Autoimmune Encephalomyelitis

S. Miller, B. Schreiner, E. McMahon, 2007, Annals of the New York Academy of Sciences.

Targeting the TCR: T-Cell Receptor and Peptide-Specific Tolerance–Based Strategies for Restoring Self-Tolerance in CNS Autoimmune Disease

S. Miller, D. Turley, A. Kohm, 2005, International reviews of immunology.

CD154 Blockade Results in Transient Reduction in Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease

S. Miller, M. D. Dal Canto, L. Haynes, 2003, Journal of Virology.

Molecular control of monocyte development.

S. Miller, Rachael L. Terry, 2014, Cellular immunology.

The role of antigen presenting cells in multiple sclerosis.

S. Miller, Emily M. L. Chastain, J. M. Rodgers, 2011, Biochimica et biophysica acta.

Epitope spreading in immune-mediated diseases: implications for immunotherapy

S. Miller, C. Vanderlugt, C. L. Vanderlugt, 2002, Nature Reviews Immunology.

Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis

S. Bhattacharyya, J. Varga, S. Miller, 2020, iScience.

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis

S. Miller, H. Waldner, E. McMahon, 2005, Nature Medicine.

Targeting the B7 Family of Co-Stimulatory Molecules

S. Miller, J. Podojil, 2013, BioDrugs.

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

S. Miller, J. Croxford, J. Croxford, 2003 .

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212.

S. Miller, J. Croxford, 2003, The Journal of clinical investigation.

Mechanisms of genetic control of immune responses

S. Miller, M. Jenkins, M. Kennedy, 1986, Immunogenetics.

Mechanisms of genetic control of immune responses

S. Miller, C. Waltenbaugh, R. Melvold, 2004, Immunogenetics.

The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C

S. Miller, H. Lipton, R. Melvold, 1987, Journal of Neuroimmunology.

THE ROLE OF SUPPRESSOR T CELL NETWORKS IN THE REGULATION OF DNFB CONTACT SENSITIVITY: Receptor‐Anti‐Receptor Interactions In Efferent Suppression *

S. Miller, L. Butler, Henry N. Claman, 1982, Annals of the New York Academy of Sciences.

HAPTEN‐SPECIFIC CELL‐MEDIATED LYMPHOLYSIS UNRESPONSIVENESS

S. Miller, L. Butler, Henry N. Claman, 1982 .

Monoclonal antibody-induced inhibition of relapsing EAE in SJL/J mice correlates with inhibition of neuroantigen-specific cell-mediated immune responses

S. Miller, M. Kennedy, J. Trotter, 1987, Journal of Neuroimmunology.

Differential recognition of peptide analogs by naive verses activated PLP 139–151-specific CD4+ T cells

S. Miller, W. Karpus, B. Mcrae, 1995, Journal of Neuroimmunology.

Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo

K. Vasquez, J. Peterson, S. Miller, 2013, Journal of Neuroinflammation.

Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expanding myelin antigen-specific Foxp3+ regulatory T cells.

T. Korn, M. Oukka, S. Miller, 2007, International immunology.

CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE

S. Miller, B. Schreiner, E. McMahon, 2007, Nature Immunology.

Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.

S. Miller, M. Sleeman, A. Prat, 2017, Journal of autoimmunity.

Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection

S. Miller, B. Hering, Xunrong Luo, 2015, Cell transplantation.

Expression of functional NK‐1 receptors in murine microglia

K. Bost, S. Miller, I. Marriott, 2002, Glia.

99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Triggering of autoimmune diseases by infections

S. Miller, S. Miller, M. T. Getts, 2010, Clinical and experimental immunology.

Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell–Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis

S. Miller, Bin Zhang, I. Ifergan, 2016, The Journal of Immunology.

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study.

Tsung-Teh Wu, J. Murray, S. Meri, 2021, Gastroenterology.

Pre-clinical and Clinical Implications of “Inside-Out” vs. “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis

S. Miller, B. Popko, J. Podojil, 2020, Frontiers in Cellular Neuroscience.

Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease1

S. Miller, A. M. Ercolini, Anne M. Ercolini, 2006, The Journal of Immunology.

CTLA-4 : A Negat ive Regulator

J. Bluestone, S. Miller, T. Walunas, 2003 .

The immunopathogenesis and regulation of

S. Miller, W. Karpus, 1994 .

Viruses, Autoimmunity, and Cancer†

S. Miller, M. T. Getts, L. Bogaert, 2010 .

Molecular Mimics Can Induce Novel Self Peptide-Reactive CD4+ T Cell Clonotypes in Autoimmune Disease1

S. Miller, A. M. Ercolini, Anne M. Ercolini, 2007, The Journal of Immunology.

Autoimmune Disease T Cell Clonotypes in + Peptide-Reactive CD 4 Molecular Mimics Can Induce Novel Self

S. Miller, A. M. Ercolini, Anne M. Ercolini, 2007 .

A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes.

S. Miller, M. V. von Herrath, D. McGavern, 2004, The Journal of clinical investigation.

Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading

S. Miller, R. Yauch, C. Vanderlugt, 1997, Nature Medicine.

Therapeutic Immune Tolerance Approaches for the Treatment of Allergic Disease

S. Miller, D. Getts, Charles B. Smarr, 2016 .

In vitro assays of allosensitization

S. Miller, U. Ekong, M. O'gorman, 2009, Pediatric transplantation.

Distinct roles of protein kinase R and toll‐like receptor 3 in the activation of astrocytes by viral stimuli

B. Williams, S. Miller, P. Carpentier, 2007, Glia.

Class I‐deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination

S. Miller, M. D. Dal Canto, Byung S. Kim, 1993, European journal of immunology.

Have we overestimated the benefit of human(ized) antibodies?

Stephen D Miller, S. Miller, D. McCarthy, 2010, mAbs.

ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses

A. Toporik, Amit Novik, Z. Levine, 2018, The Journal of Immunology.

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche

C. Thaxton, O. Volpert, I. Osman, 2017, Nature Communications.

Pattern Recognition Receptors in CNS Disease

S. Miller, P. Carpentier, D. S. Duncan, 2008, Central Nervous System Diseases and Inflammation.

Potential for Targeting Myeloid Cells in Controlling CNS Inflammation

S. Miller, I. Ifergan, 2020, Frontiers in Immunology.

The Contribution of γδ T Cells to the Pathogenesis of EAE and MS

S. Miller, Sarah E. Blink, 2009 .

B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex

Lieping Chen, H. Chi, S. Langermann, 2018, The Journal of Immunology.

B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms.

Lieping Chen, S. Langermann, S. Miller, 2013, Journal of autoimmunity.

Experimental Autoimmune Encephalomyelitis in the Mouse

S. Miller, W. Karpus, Z. Fabry, 2021, Current protocols.

Experimental Autoimmune Encephalomyelitis in Mice.

S. Miller, Rachael L. Terry, I. Ifergan, 2016, Methods in molecular biology.

Encephalomyelitis Experimental Autoimmune Age-associated Onset of Spontaneous Intrinsic and Induced Regulation of the Intrinsic and Induced Regulation of the Age-associated Onset of Spontaneous Experimental Autoimmune Encephalomyelitisa-7 and Rg 3965-a-8, and a Grant from the Myelin Repair Foundatio

S. Miller, Hong Zhang, Xunrong Luo, 2022 .

Hematopoietic cell activation in the subventricular zone after Theiler's virus infection

S. Miller, G. Goings, F. Szele, 2008, Journal of Neuroinflammation.

Molecular mechanisms of T‐cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy

S. Miller, J. Podojil, Joseph R. Podojil, 2009, Immunological reviews.

Differential Role of B Cells and IL-17 Versus IFN-&ggr; During Early and Late Rejection of Pig Islet Xenografts in Mice

S. Miller, B. Hering, Xunrong Luo, 2017, Transplantation.

Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma

P. Robson, S. Miller, Yanni Yu, 2019, bioRxiv.

Pak2 is essential for the function of Foxp3+ regulatory T cells through maintaining a suppressive Treg phenotype

S. Miller, H. Phee, Kyle L O'Hagan, 2017, Scientific Reports.

Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic

S. Miller, Robert H Miller, B. Popko, 2015, Nature Communications.

Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy

S. Miller, G. Goings, S. Koh, 2018, The Journal of experimental medicine.

Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions

S. Miller, Richard J. Miller, J. Podojil, 2016, Journal of Neuroimmune Pharmacology.

Helper T cell subsets and control of the inflammatory response

S. Miller, T. Eagar, 2008 .

Nf1 Loss and Ras Hyperactivation in Oligodendrocytes Induce NOS-Driven Defects in Myelin and Vasculature

A. Stemmer-Rachamimov, C. Vorhees, N. Ratner, 2013, Cell reports.

Targeted immunomodulation using antigen-conjugated nanoparticles.

S. Miller, L. Shea, D. McCarthy, 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease.

S. Miller, J. Podojil, D. Turley, 2008, Advances in experimental medicine and biology.

Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the Non-Obese Diabetic (NOD) Mouse.

S. Miller, R. Gill, K. Haskins, 2022, Diabetes.

Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice

S. Miller, J. Kessler, D. McCarthy, 2017, Neurobiology of Disease.

Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis.

S. Miller, D. Getts, M. T. Getts, 2008, Therapy.

Temporal Development of Autoreactive Th1 Responses and Endogenous Presentation of Self Myelin Epitopes by Central Nervous System-Resident APCs in Theiler’s Virus-Infected Mice1

S. Miller, C. Vanderlugt, J. Olson, 2000, The Journal of Immunology.

Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis.

S. Miller, B. Popko, R. Balabanov, 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Can Immune Tolerance Be Re-established in Neuromyelitis Optica?

S. Miller, R. Balabanov, Eileah Loda, 2021, Frontiers in Neurology.

A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination.

S. Miller, B. Soliven, M. Traka, 2010, Brain : a journal of neurology.

Paranodal myelin retraction in relapsing experimental autoimmune encephalomyelitis visualized by coherent anti-Stokes Raman scattering microscopy.

Ji-Xin Cheng, Yan Fu, Stephen D Miller, 2011, Journal of biomedical optics.

Upregulation of the stress‐associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues

M. Carson, J. Iovanna, S. Miller, 2006, Glia.

ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance

Amit Novik, E. Neria, S. Miller, 2018, The Journal of Immunology.

T Regulatory + CD25+ Depletion, of CD4 Results in the Functional Inactivation, Not Anti-CD25 Monoclonal Antibody Injection Response to Comment on ''Cutting Edge:

S. Miller, A. Kohm, Stephen D. Miller, 2006 .

Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regulatory T cells.

S. Miller, A. Kohm, P. Carpentier, 2003, Novartis Foundation symposium.

Towards cannabis and cannabinoid treatment of multiple sclerosis.

S. Miller, J. Croxford, 2004, Drugs of today.

Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

S. Miller, M. T. Getts, P. Carpentier, 2008, Virology.

Intravenous Immunomodulatory Nanoparticle Treatment for Traumatic Brain Injury

R. Linsenmeier, S. Miller, J. Kessler, 2020, Annals of neurology.

Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis

R. Oakes, S. Miller, L. Shea, 2020, Nature Communications.

Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis

Stephen D Miller, S. Miller, C. Mack, 2003, Journal of Neuroimmunology.

The contribution of gammadelta T cells to the pathogenesis of EAE and MS.

S. Miller, Sarah E. Blink, 2009, Current molecular medicine.

Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia

P. Gebicke-haerter, M. Rossner, S. Miller, 2023, Frontiers in Immunology.

Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell–Mediated Central Nervous System Autoimmune Disease

S. Miller, M. Chiang, W. Muller, 2016, The Journal of Immunology.

Cross-Immunoreactivity between Bacterial Aquaporin-Z and Human Aquaporin-4: Potential Relevance to Neuromyelitis Optica

S. Miller, Tao Duan, R. Balabanov, 2012, The Journal of Immunology.

CNS Dendritic Cells in Inflammation and Disease

S. Miller, S. Bailey, 2008 .

Experimental Autoimmune Encephalomyelitis in the Mouse

S. Miller, W. Karpus, 1996 .

B7-CD28/CTLA-4 costimulatory pathways in intrinsic and induced regulation of CD4 T cell-mediated autoimmune diseases

J. Bluestone, D. Lenschow, S. Miller, 1997 .

Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis

S. Miller, Richard J. Miller, S. Lanker, 2014, Journal of Neuroimmune Pharmacology.

Erratum: Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice (The Journal of Experimental Medicine (September 3, 2001) 194:5 (677-684))

A. Montag, J. Bluestone, H. Hsin, 2001 .

Detection of suppressor cells and suppressor factors for delayed-type hypersensitivity responses

S. Miller, M. Jenkins, Miller Sd, 1986 .

Increased Detection of KIT D816V Mutation in Peripheral Blood Samples from Patients with Indolent Systemic Mastocytosis (ISM) in the Phase 2 Pioneer Study Using a High Sensitivity Droplet Digital (dd) PCR Assay Compared with Next Generation Sequencing (NGS)

G. Hoehn, T. George, S. Miller, 2020, Blood.

MicroRNA-managing the TH-17 inflammatory response

Aaron J. Martin, Liang Zhou, S. Miller, 2009, Nature Immunology.

CTLA-4: a negative regulator of autoimmune disease

Nitin J. Karandikar, J. Bluestone, S. Miller, 1996, The Journal of experimental medicine.

Bacteriology and Treatment: A Prospective Study

E. P. Dellinger, S. Miller, M. Coyle, 2017 .

Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

S. Miller, J. Olson, J. Croxford, 2004, Methods in molecular medicine.

The role of infections in autoimmune disease

S. Miller, S. Miller, A. M. Ercolini, 2009, Clinical and experimental immunology.

Epitope spreading

S. Miller, Carol J. Vanderlugt, 1996, Current Opinion in Immunology.

Epitope spreading: lessons from autoimmune skin diseases.

T. Nishikawa, S. Miller, K. Gordon, 1998, The Journal of investigative dermatology.

Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.

L. Matis, S. Miller, K. Gordon, 1998, Journal of immunology.

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

S. Miller, C. Vanderlugt, S. Miller, 1995, The Journal of experimental medicine.

Anergy in vivo: down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses.

J. Peterson, S. Miller, W. Karpus, 1994, International immunology.

Theiler's Murine Encephalomyelitis Virus (TMEV)-Induced Demyelination: A Model for Human Multiple Sclerosis

S. Miller, Byung S. Kim, R. Melvold, 1996, Methods.

Astrocytes in multiple sclerosis: A product of their environment

S. Miller, S. Miller, T. J. Frederick, 2008, Cellular and Molecular Life Sciences.

Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.

S. Miller, R. Noelle, R. Noelle, 1999, The Journal of clinical investigation.

Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519.

P. Elliott, S. Miller, C. Vanderlugt, 2000, Journal of autoimmunity.

Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor.

S. Miller, S. Miller, G. Green, 1993, Regional immunology.

A virus-induced molecular mimicry model of multiple sclerosis.

S. Miller, S. Miller, M. Calenoff, 2001, Current topics in microbiology and immunology.

Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin.

S. Miller, S. Miller, D. Hanson, 1979, Journal of immunology.

Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor T cells.

S. Miller, S. Miller, D. Hanson, 1982, Journal of immunology.

Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.

V. Kuchroo, S. Miller, B. Theien, 2001, The Journal of clinical investigation.

Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.

S. Miller, S. Miller, M. Kennedy, 1992, Journal of immunology.

Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides.

V. Tuohy, S. Miller, S. Miller, 1990, Journal of immunology.

The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases.

S. Miller, W. Karpus, S. Miller, 1994, Immunology today.

Active suppression of 1-fluoro-2,4-dinitrobenzene-immune T cells. Requirement of an auxiliary T cell induced by antigen

S. Miller, M. Sy, S. Miller, 1979, The Journal of experimental medicine.

Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.

J. Peterson, S. Miller, W. Karpus, 1994, Journal of immunology.

Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice.

S. Miller, S. Miller, H. Lipton, 1991, Journal of immunology.

Induction of antigen-specific tolerance for the treatment of ongoing, relapsing autoimmune encephalomyelitis: a comparison between oral and peripheral tolerance.

S. Miller, W. Karpus, W. S. Smith, 1997, Journal of immunology.

Elevated levels of serum immunoglobulins in asymptomatic carriers of Clostridium difficile.

S. Miller, M. Mulligan, H. Fung, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis.

S. Miller, R. Burt, S. Miller, 1998, Blood.

Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction.

S. Miller, S. Miller, M. D. Dal Canto, 1990, Journal of immunology.

Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.

S. Miller, C. Vanderlugt, S. Miller, 1998, Journal of immunology.

Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.

S. Miller, S. Miller, H. Lipton, 1986, Journal of immunology.

Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.

S. Miller, S. Miller, H. Lipton, 1985, Journal of immunology.

Tempering Allorecognition to Induce Transplant Tolerance With Chemically Modified Apoptotic Donor Cells

S. Miller, S. Miller, D. McCarthy, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction.

J. Peterson, S. Miller, W. Karpus, 1995, Journal of immunology.

T Regulatory + CD25+ Depletion, of CD4 Results in the Functional Inactivation, Not Anti-CD25 Monoclonal Antibody Injection Response to Comment on ''Cutting Edge:

S. Miller, A. Kohm, Stephen D. Miller, 2006 .

NLRP 3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th 1 and Th 17 Responses

Denis Gris, Z. Ye, H. Iocca, 2010 .

Virus infection, antiviral immunity, and autoimmunity

S. Miller, D. Getts, Rachael L. Terry, 2013, Immunological Reviews.

Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions.

John G. Graham, S. Miller, D. Kaufman, 2011, Biomaterials.

Targeting the B7 Family of Co-Stimulatory Molecules

S. Miller, J. Podojil, Joseph R. Podojil, 2012, BioDrugs.